News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
373,202 Results
Type
Article (25675)
Company Profile (66)
Press Release (347461)
Section
Business (104212)
Career Advice (454)
Deals (16871)
Drug Delivery (42)
Drug Development (47509)
Employer Resources (48)
FDA (12229)
Job Trends (8419)
News (185780)
Policy (19405)
Tag
Academia (1730)
Allergies (45)
Alliances (26531)
Alzheimer's disease (712)
Approvals (12182)
Artificial intelligence (71)
Bankruptcy (137)
Best Places to Work (6792)
Breast cancer (79)
Cancer (583)
Cardiovascular disease (62)
Career advice (411)
Cell therapy (101)
Clinical research (39155)
Collaboration (184)
COVID-19 (1445)
Data (593)
Diabetes (83)
Diagnostics (3334)
Drug pricing (45)
Earnings (35653)
Employer resources (46)
Events (50105)
Executive appointments (159)
FDA (12573)
Funding (152)
Gene therapy (60)
GLP-1 (304)
Government (2990)
Healthcare (12122)
Infectious disease (1486)
Inflammatory bowel disease (65)
IPO (6967)
Job creations (1837)
Job search strategy (383)
Layoffs (149)
Legal (3626)
Liver cancer (47)
Lung cancer (118)
Manufacturing (54)
Medical device (12670)
Medtech (12673)
Mergers & acquisitions (9952)
Metabolic disorders (221)
Neuroscience (859)
NextGen Class of 2024 (3925)
Non-profit (2812)
Northern California (628)
Obesity (131)
Opinion (60)
Patents (50)
People (34002)
Phase I (11172)
Phase II (16954)
Phase III (13937)
Pipeline (124)
Postmarket research (1668)
Preclinical (3493)
Radiopharmaceuticals (156)
Rare diseases (86)
Real estate (2843)
Regulatory (13613)
Research institute (1597)
Resumes & cover letters (51)
Southern California (565)
Startups (2116)
United States (6430)
Vaccines (279)
Weight loss (101)
Date
Today (43)
Last 7 days (393)
Last 30 days (1543)
Last 365 days (20109)
2024 (17017)
2023 (22746)
2022 (30696)
2021 (33007)
2020 (32212)
2019 (28430)
2018 (21834)
2017 (18919)
2016 (18124)
2015 (21216)
2014 (16030)
2013 (13251)
2012 (14353)
2011 (14631)
2010 (13187)
Location
Africa (353)
Arizona (85)
Asia (23970)
Australia (3794)
California (1371)
Canada (696)
China (134)
Colorado (73)
Connecticut (72)
Delaware (43)
Europe (46760)
Florida (256)
Georgia (59)
Illinois (204)
Indiana (121)
Kansas (67)
Maryland (384)
Massachusetts (1008)
Michigan (59)
Minnesota (163)
New Hampshire (51)
New Jersey (511)
New York (457)
North Carolina (377)
Northern California (628)
Ohio (77)
Pennsylvania (456)
South America (518)
Southern California (565)
Texas (234)
Washington State (122)
373,202 Results for "outset medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Outset Medical to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the Goldman Sachs 45th annual Healthcare conference on Wednesday, June 12, 2024, at 11:20 a.m. Eastern time.
June 3, 2024
·
1 min read
Biotech Bay
Outset Medical’s TabloCart with Prefiltration Receives FDA 510(k) Clearance
Outset Medical, Inc. (Nasdaq: OM) (“Outset”) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of TabloCartTM with prefiltration, an innovative optional accessory for the Tablo® Hemodialysis System.
May 6, 2024
·
3 min read
Business
Outset Medical Reports First Quarter 2024 Financial Results
Outset Medical, Inc., a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, reported financial results for the first quarter ended March 31, 2024.
May 8, 2024
·
14 min read
Business
Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024
October 23, 2024
·
1 min read
Business
Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Outset Medical, Inc. today announced that it will release financial results for the first quarter of 2024 after the close of trading on Wednesday, May 8, 2024.
April 19, 2024
·
1 min read
Business
Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care
Outset Medical, Inc. today announced its partnership with the American Nephrology Nurses Association (ANNA) as a member of its new Partnership Advisory Council.
April 15, 2024
·
4 min read
Biotech Bay
Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.
Outset Medical, Inc. announced today a multi-year agreement to help accelerate home hemodialysis in the U.S.
April 17, 2024
·
4 min read
Business
Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors
Outset Medical, Inc., a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced the appointment of medical technology veteran Brent D. Lang to its board of directors.
March 13, 2024
·
3 min read
Business
Outset Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2023.
February 21, 2024
·
16 min read
Biotech Bay
Outset Medical to Present at the 44th Annual TD Cowen Health Care Conference
Outset Medical, Inc. today announced that members of management will present at the 44th annual TD Cowen Health Care conference on Tuesday, March 5, 2024, at 1:30 p.m. Eastern time.
February 26, 2024
·
1 min read
1 of 37,321
Next